INVIMA announced the activation of a new functionality within the InvimÁgil platform that enables the generation of Certificates of Free Sale (CVL) with observations. This enhancement is intended to improve the management, clarity, and traceability of certificates issued through the authority’s digital regulatory system.
By allowing observations to be incorporated directly into the CVL, the update supports more efficient regulatory operations and facilitates clearer communication between the authority and regulated entities. This functionality contributes to improved handling of regulatory documentation associated with medicinal products, particularly in contexts related to commercialization and export.
INVIMA’s decision to implement and communicate this update reflects the authority’s ongoing efforts to strengthen digital regulatory infrastructure and streamline interactions with regulated stakeholders. The enhancement aligns with broader initiatives aimed at modernizing regulatory processes while maintaining transparency and traceability.
Key Highlights
- Enhanced CVL Functionality
Enables the issuance of Certificates of Free Sale with observations through InvimÁgil, improving transparency and completeness of information included in official certificates. - Digital Regulatory Operations
Strengthens InvimÁgil as a core platform for regulatory procedures, supporting more efficient processing and reducing administrative friction for regulated entities. - Operational Impact
Relevant for companies requiring CVLs for regulatory, commercial, or export-related purposes, enhancing traceability and clarity in certificate management processes. - Non-Mandatory Nature
This update does not introduce new regulatory obligations or compliance deadlines and should be understood as an operational improvement within an existing regulatory system.